September 29, 2016 1:09 PM ET

Pharmaceuticals

Company Overview of Decibel Therapeutics, Inc.

Executive Profile

Kevin P. Starr

Founder and Chairman, Decibel Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 6 Board Members in 6 different organizations across 13 different industries.

See Board Relationships
53--

Background

Mr. Kevin P. Starr serves as the Chairman of Afferent Pharmaceuticals, Inc. and served as its Partner. Mr. Starr co-founded Third Rock Ventures, LLC in 2007 and is its Partner. He focuses on the formation, development, and business strategy of Therapeutics’ portfolio companies as well as actively identifying and evaluating new investments. He assumes active leadership roles in the portfolio companies, functioning as the Chief Executive Officer through the first 12 to ...

Corporate Headquarters

215 First Street
Cambridge, Massachusetts 02142

United States

Phone: 973-271-6085
Fax: --

Board Members Memberships

Director
Founder and Chairman
2003-Present
Director and Chairman of Audit Committee
2009-Present
Chairman of Board of Directors
2011-Present
Chairman
2012-Present
Director and Member of Audit Committee

Education

MS
Boston College
BA
Colby College

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Decibel Therapeutics, Inc., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.